iwCLL 2019 | Five-year follow up of the UK CLL Forum ibrutinib data

[Jm954]

Dr Toby Eyre, MD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses the UK chronic lymphocytic leukemia (CLL) forum study led by George Follows, Cambridge University Hospitals, Cambridge, UK, and the 5-year follow up data for ibrutinib in R/R CLL.

This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

vjhemonc.com/video/22gk1jpd...

Jackie

(Skip the registration to view the video by just selecting "Continue" - Neil)

[Wroxham]

Hi Jackie

Dr Toby Eyre MD. Is this a new specialist

in CLL at Oxford.?

Thank you.

Sue

[Jm954 Administrator in reply to Wroxham]

Yes, I think so. He seems really good.

[Wroxham in reply to Jm954]

Thanks Jackie. One to watch.

Sue

[Wroxham]

Does this CLL UK forum cover all patients taking Ibrutinib or just the patients in a trial?

Many thanks.

Sue

[Jm954 Administrator in reply to Wroxham]

They look at trial data but because the patients in the trial are within a very narrow type that had to fulfill the inclusion and exclusion criteria they also look at what is called 'real world data' - which is everyone else, if their consultant takes part

Jackie

[Wroxham in reply to Jm954]

Thank Jackie. That makes it more interesting and accurate we hope.

Regards

Sue